Steven J. Milner

421 total citations
12 papers, 377 citations indexed

About

Steven J. Milner is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Steven J. Milner has authored 12 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Oncology. Recurrent topics in Steven J. Milner's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Peptidase Inhibition and Analysis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Steven J. Milner is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Peptidase Inhibition and Analysis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Steven J. Milner collaborates with scholars based in Australia. Steven J. Milner's co-authors include Geoffrey L. Francis, John C. Wallace, F J Ballard, Kerrie A. McNeil, M Ross, J. R. E. Wells, Perry J. Hartfield, Briony E. Forbes, Leah Cosgrove and Kathy H. Surinya and has published in prestigious journals such as Biochemical Journal, European Journal of Biochemistry and Archives of Biochemistry and Biophysics.

In The Last Decade

Steven J. Milner

12 papers receiving 361 citations

Peers

Countries citing papers authored by Steven J. Milner

Since Specialization

Citations

This map shows the geographic impact of Steven J. Milner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Milner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Milner more than expected).

Fields of papers citing papers by Steven J. Milner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Milner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Milner. The network helps show where Steven J. Milner may publish in the future.

Co-authorship network of co-authors of Steven J. Milner

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Milner. A scholar is included among the top collaborators of Steven J. Milner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Milner. Steven J. Milner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	A Case for Below-Ground Dispersal? Insights into the Biology, Ecology and Conservation of Blind Cave Spiders in the Genus Troglodiplura (Mygalomorphae: Anamidae) 2023 ·Insects ·(unknown), Steven J. Milner, Matthew D. Shaw, Andrew J. Stempel, Mark S. Harvey, Michael G. Rix	2
2	Characteristics of binding of insulin‐like growth factor (IGF)‐I and IGF‐II analogues to the type 1 IGF receptor determined by BIAcore analysis 2002 ·European Journal of Biochemistry ·Briony E. Forbes, Perry J. Hartfield, Kerrie A. McNeil, Kathy H. Surinya, Steven J. Milner, Leah Cosgrove, John C. Wallace	53
3	Linkers for improved cleavage of fusion proteins with an engineered α‐lytic protease 2001 ·Biotechnology and Bioengineering ·Samantha Lien, Steven J. Milner, Lloyd D. Graham, John C. Wallace, Geoffrey L. Francis	13
4	Linkers for improved cleavage of fusion proteins with an engineered α‐lytic protease 2001 ·Biotechnology and Bioengineering ·Samantha Lien, Steven J. Milner, Lloyd D. Graham, John C. Wallace, Geoffrey L. Francis	1
5	Probing the disulfide folding pathway of insulin-like growth factor-I 1999 ·Biotechnology and Bioengineering ·Steven J. Milner, John A. Carver, F J Ballard, Geoffrey L. Francis	28
6	Probing the disulfide folding pathway of insulin‐like growth factor‐I 1999 ·Biotechnology and Bioengineering ·Steven J. Milner, John A. Carver, F J Ballard, Geoffrey L. Francis	1
7	Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin-like growth factor (IGF)-I 1996 ·Biotechnology and Bioengineering ·Steven J. Milner, (unknown), F J Ballard, Geoffrey L. Francis	8
8	Studies into the scale-up of a process to produce a biosynthetic insulin-like growth factor. 1995 ·Food and Bioproducts Processing ·(unknown), (unknown), Steven J. Milner, Geoffrey L. Francis, Brian K. O’Neill, (unknown)	2
9	Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties 1995 ·Biochemical Journal ·Steven J. Milner, Geoffrey L. Francis, John C. Wallace, (unknown), F J Ballard	28
10	Purification and Characterization of S1 Mutants of α-Lytic Protease Having Altered Catalytic Properties 1994 ·Archives of Biochemistry and Biophysics ·(unknown), Lloyd D. Graham, Steven J. Milner, Roger G. Whittaker	4
11	Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II 1993 ·Biochemical Journal ·Geoffrey L. Francis, (unknown), Steven J. Milner, Kerrie A. McNeil, F J Ballard, John C. Wallace	76
12	Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency 1992 ·Journal of Molecular Endocrinology ·Geoffrey L. Francis, M Ross, F J Ballard, Steven J. Milner, (unknown), Kerrie A. McNeil, John C. Wallace, (unknown), J. R. E. Wells	161

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact